These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 21666733

  • 1. Therapeutics: new drugs hit the target.
    Schlütter J.
    Nature; 2011 Jun 08; 474(7350):S5-7. PubMed ID: 21666733
    [No Abstract] [Full Text] [Related]

  • 2. The results of Phase III clinical trials with telaprevir and boceprevir presented at the Liver Meeting 2010: a new standard of care for hepatitis C virus genotype 1 infection, but with issues still pending.
    Pawlotsky JM.
    Gastroenterology; 2011 Mar 08; 140(3):746-54. PubMed ID: 21255572
    [No Abstract] [Full Text] [Related]

  • 3. Excitement grows for potential revolution in hepatitis C virus treatment.
    Opar A.
    Nat Rev Drug Discov; 2010 Jul 08; 9(7):501-3. PubMed ID: 20592732
    [No Abstract] [Full Text] [Related]

  • 4. Controlling hepatitis C with simeprevir.
    Dusheiko G.
    Lancet Infect Dis; 2015 Jan 08; 15(1):2-4. PubMed ID: 25482331
    [No Abstract] [Full Text] [Related]

  • 5. Boceprevir and telaprevir in the management of hepatitis C virus-infected patients.
    Butt AA, Kanwal F.
    Clin Infect Dis; 2012 Jan 01; 54(1):96-104. PubMed ID: 22156853
    [Abstract] [Full Text] [Related]

  • 6. Drugs in development for viral hepatitis: care and caution.
    Pockros PJ.
    Drugs; 2011 Feb 12; 71(3):263-71. PubMed ID: 21319865
    [No Abstract] [Full Text] [Related]

  • 7. Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?
    Bruno R, Fagiuoli S, Sacchi P.
    Expert Rev Anti Infect Ther; 2011 Sep 12; 9(9):699-701. PubMed ID: 21905777
    [No Abstract] [Full Text] [Related]

  • 8. Decade in review-HCV: hepatitis C therapy-a fast and competitive race.
    Zeuzem S.
    Nat Rev Gastroenterol Hepatol; 2014 Nov 12; 11(11):644-5. PubMed ID: 25223875
    [No Abstract] [Full Text] [Related]

  • 9. Boceprevir, telaprevir, and rilpivirine hydrochloride.
    Hussar DA, Snell CW.
    J Am Pharm Assoc (2003); 2012 Nov 12; 52(1):120-6. PubMed ID: 22257626
    [No Abstract] [Full Text] [Related]

  • 10. Prompt arrival of antivirals against hepatitis C for HIV patients.
    Barreiro P, Vispo E.
    AIDS Rev; 2010 Nov 12; 12(4):242-3. PubMed ID: 21344779
    [No Abstract] [Full Text] [Related]

  • 11. Hepatitis C in 2012.
    Lemon M.
    S D Med; 2012 Nov 12; 65(11):432-3. PubMed ID: 23189411
    [No Abstract] [Full Text] [Related]

  • 12. Viral hepatitis C in 2014--the beginning of the end?
    Prelipcean CC, Gogălniceanu P, Mihai C.
    Rev Med Chir Soc Med Nat Iasi; 2014 Nov 12; 118(2):272-8. PubMed ID: 25076687
    [No Abstract] [Full Text] [Related]

  • 13. [Future of antiviral therapy for chronic hepatitis C. Direct antiviral acting medications].
    Lange CM, Sarrazin C, Zeuzem S.
    Pharm Unserer Zeit; 2011 Jan 12; 40(1):60-7. PubMed ID: 21194084
    [No Abstract] [Full Text] [Related]

  • 14. New developments in HCV therapy.
    Kronenberger B, Zeuzem S.
    J Viral Hepat; 2012 Jan 12; 19 Suppl 1():48-51. PubMed ID: 22233414
    [Abstract] [Full Text] [Related]

  • 15. Analysis of sequence configurations of the PKR-interacting HCV proteins from plasma and PBMC as predictors of response to interferon-alpha and ribavirin therapy in HIV-coinfected patients.
    Bolcic F, Bull L, Martinez L, Reynoso R, Salomon H, Arduino R, Barnett B, Quarleri J.
    Intervirology; 2008 Jan 12; 51(4):261-4. PubMed ID: 18824873
    [No Abstract] [Full Text] [Related]

  • 16. Simeprevir for hepatitis C virus.
    Hutcheson S, Klibanov OM.
    Nurse Pract; 2014 Sep 18; 39(9):10-2. PubMed ID: 25140845
    [No Abstract] [Full Text] [Related]

  • 17. [Victrelis and Incivek against hepatitis C: some promising options].
    Sabourin G.
    Perspect Infirm; 2012 Sep 18; 9(1):58-9. PubMed ID: 22295460
    [No Abstract] [Full Text] [Related]

  • 18. TMC435 for the treatment of chronic hepatitis C.
    Tanwar S, Trembling PM, Dusheiko GM.
    Expert Opin Investig Drugs; 2012 Aug 18; 21(8):1193-209. PubMed ID: 22616626
    [Abstract] [Full Text] [Related]

  • 19. [Hepatitis C virus genotype 4: epidemiology and treatment].
    Castera L, Morice Y, Grando V, Bon C, Dény P, Roulot D.
    Gastroenterol Clin Biol; 2003 Jun 18; 27(6-7):596-604. PubMed ID: 12910223
    [No Abstract] [Full Text] [Related]

  • 20. [Boceprevir and telaprevir: clinical efficacy, safety and drug-drug interactions].
    Nikitin AV.
    Antibiot Khimioter; 2012 Jun 18; 57(9-10):47-9. PubMed ID: 23477220
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.